Advertisement
YOU ARE HERE: LAT HomeCollectionsFda
IN THE NEWS

Fda

BUSINESS
February 2, 2012 | By Matt Stevens
Trace levels of the fungicide carbendazim were discovered in domestic orange juice samples, the Food and Drug Administration reported Thursday. But the FDA said the levels pose no safety risk, and the orange juice will not be recalled. FDA spokeswoman Siobhan DeLancey said that most of the samples taken were from concentrated products that will be blended down into the orange juice consumers drink, so the low levels of carbendazim will almost disappear. “We didn't have any evidence to indicate that the product on the market was any safety problem at all,” DeLancey said.
Advertisement
NEWS
September 14, 2010
The Food and Drug Administration released information Tuesday suggesting it's unimpressed by a weight-loss medication under development by Arena Pharmaceuticals Inc. and casting doubt on the drug's eventual approval. An FDA advisory committee is scheduled to meet Thursday and vote on whether to recommend approval of the drug, lorcaserin. But in documents released Tuesday in advance of the meeting, the FDA noted that studies on lorcaserin showed the average weight loss while taking the drug was not significantly different than the average weight loss among people taking a placebo.
BUSINESS
October 30, 2013 | By David Pierson
About 12% of spices imported into the U.S. each year is contaminated with insects, animal excrement, rodent hair and even rubber bands, according to a Food and Drug Administration draft report released Wednesday. The study was conducted in response to recent cases of salmonella found in imported spices. It looked at ways to reduce the rates of human illness caused by contamination in the seasonings. “Nearly all of the insects found in spice samples were stored product pests, indicating inadequate packing or storage conditions.
NEWS
March 21, 2013 | By Monte Morin
La Preferida Inc. is voluntarily recalling 56,808 29-ounce cans of La Preferida Whole Pinto Beans, the U.S. Food and Drug Administration announced Thursday. "The manufacturer's preliminary inspection indicates 420 cans may not have been fully processed, which could result in product contamination by spoilage organisms or by pathogens, which could lead to illness if consumed," the FDA said. "To date, there have been no reported injuries or adverse events associated with the consumption of this product.
SCIENCE
June 18, 2013 | By Melissa Healy
The Food and Drug Administration says it is investigating the unexplained deaths of two patients in the wake of receiving intramuscular injections of the antipsychotic medication Zyprexa (generic name olanzapine). The patients died three to four days after receiving appropriate doses of Zyprexa Relprevv, which is designed to release slowly into the blood over two to four weeks and provide regular dosing for adults with schizophrenia. The FDA says the deaths occurred well after the three-to-four-hour window following injection during which patients should be monitored in a physician's office for a potentially deadly complication called post-injection delirium sedation syndrome (PDSS)
NEWS
January 7, 2011 | By Amina Khan, Los Angeles Times
By late March, tobacco companies will have to reveal to the Food and Drug Administration what sorts of new additives they've recently put in their products. But the ruling doesn't apply to electronic cigarettes, whose makers are locked in legal battle with the FDA. Meanwhile, the e-cigs are starting to gain a pop-culture foothold – in the fall film “The Tourist,” actor Johnny Depp extols the devices’ virtues to Angelina Jolie, and Katherine Heigl showed up recently on the "Late Show with David Letterman" smoking the e-cigarette indoors.
BUSINESS
February 12, 2014 | By Ricardo Lopez
The U.S. Food and Drug Administration is investigating the illnesses of children in three states in recent months that have been linked to Uncle Ben's infused rice served in schools. The cluster of illnesses have affected children in Texas, Illinois and North Dakota. At three schools in Katy, Texas, 34 students and four teachers experienced skin reactions, burning, headaches and nausea last week after eating Uncle Ben's "Mexican flavor" infused rice.  The symptoms lasted about 90 minutes, officials said.  Similar reactions were reported at an Illinois school in December and a daycare center in North Dakota in October.  Mars Foodservices, which produces the product, has recalled 5- and 25-pound bags of various rice products primarily sold to schools, restaurants, hospitals and other commercial establishments.
NEWS
December 27, 2010 | By Mary Forgione, For the Los Angeles Times
Remoxy may not have the name recognition of Percocet, but its makers say it has something Percocet and similar drugs don't have -- little potential for addiction. They've asked, again, that the FDA approve Remoxy. Like Percocet, Remoxy contains oxycodone, an opiate that Americans like quite a bit. Unlike other formulations, however, Remoxy employs a special controlled-release formula designed to limit its abuse. The National Institute on Drug Abuse reports that of 7 million Americans abusing prescription drugs in 2009, 5.3 million were abusing pain relievers.
NEWS
June 21, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
The Food and Drug Administration says it could use an international helping hand in testing the influx of imported drugs and food.  Acknowledging the monitoring difficulties inherent in a global economy, the agency said in an announcement Monday that it needs to transform the way it protects the nation's food and drug supply, teaming up with other agencies around the world to ensure quality and safety of the products it regulates. “Global production of FDA-regulated goods has exploded over the past ten years.  In addition to an increase in imported finished products, manufacturers increasingly use imported materials and ingredients in their U.S. production facilities, making the distinction between domestic and imported products obsolete,” Commissioner of Food and Drugs Margaret A. Hamburg said in the announcement.
NEWS
June 23, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
The Food and Drug Administration is essentially telling U.S. consumers worried about silicone breast implants: “Told you so.” But in releasing new research backing up its 2006 decision to allow the implants back onto the market, the agency also reminds women, in a way, that they have only two choices — silicone or saline. So let’s take a look at those options. Until 2006, silicone implants had been under a 14-year ban by the FDA because of concerns that leaks or ruptures could increase the risk of certain diseases, including breast cancer and connective tissue diseases.
Los Angeles Times Articles
|